Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christopher Kabrhel, M.D.

Profile Picture

University of North Carolina at Chapel Hill, Chapel Hill, NCBA1994Philosophy and Biology
Johns Hopkins School of Medicine, Baltimore, MDMD1999Medicine
Harvard School of Public Health, Boston, MAMPH2008Clinical Effectiveness

Available: 02/05/24, Expires: 02/01/25

Pulmonary embolism (PE) remains a significant cause of morbidity and mortality and is a critical “cannot miss” diagnosis in the Emergency Department (ED). Despite this, it is difficult to diagnose as the spectrum of disease ranges from patients being asymptomatic to having hemodynamic instability and cardiopulmonary collapse. Due to this challenge, there has been a lot of work to create clinical decision rules, such as the Pulmonary Embolism Rule Out Criteria (PERC) Rule. The PERC Rule can be quickly applied by clinicians to determine which patients for which PE is part of the differential diagnosis are at extremely low risk for PE and do not require further diagnostic testing or for whom further diagnostic testing should be pursued. Unfortunately, due to challenges related to ED boarding and crowding, patients may wait to be seen by a clinician for many hours. This creates an environment where it is possible that a patient with a “cannot miss” diagnosis waits for hours before the appropriate work-up can be started. Fortunately, all patients that arrive in the ED are seen by skilled nursing staff who are trained in ED triage. Their role is to identify patients for whom extended waiting periods in the ED would be unsafe. They do this by collecting initial vital signs, demographic data, basic medical history, and a one to two sentence “triage note.” As one might imagine, ED triage is a high stakes, stress, and volume role. Within the Massachusetts General Hospital, there have been several quality improvement (QI) initiatives to improve ED triage including EPIC incorporated “sepsis flags” which flag a patient as “at risk” for sepsis based on their triage information. The goal of this project is to use machine learning (ML), artificial intelligence, and ChatGPT to help design an MGH ED PE flag. The goal is to recognize patients who present to the ED and are at high-risk for PE such that they can be flagged and considered for an expedited work-up for PE. The primary aim of this project will be to design, train, test, and validate ML models compared to a basic ChatGPT model, as well as nurse triage alone to determine if a high-quality model for estimating an ED patient’s probability for PE can be created from triage data alone. For this project, you will work with both Chris Kabrhel, MD, MPH, an MGH ED attending physician, director of the Center for Vascular Emergencies (CVE), and a world-renowned PE expert and Drew Birrenkott, MD, DPhil, a third-year emergency medicine resident who completed his doctorate in biomedical engineering with a focus on ML. The data for this project is derived from a data set containing all of the triage information of all patients who were deemed to be at high-enough risk for a PE that they were evaluated in the ED with a computed tomography pulmonary angiogram (CTPA), the gold standard diagnostic study for PE, whether or not they were ultimately diagnosed with a PE.

The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01HL168040 (KABRHEL, CHRISTOPHER) Sep 1, 2023 - Jul 31, 2027
    Supplemental Oxygen for Pulmonary Embolism (SO-PE) - A Mechanistic Clinical Trial
    Role: Principal Investigator
  2. R01HL116854 (KABRHEL, CHRISTOPHER) Feb 1, 2013 - Jan 31, 2019
    Genetic and Environmental Risk Factors for Venous Thromboembolism
    Role: Principal Investigator
  3. R21AG031079 (CAMARGO, CARLOS A.) Sep 30, 2007 - Aug 31, 2009
    Prospective Study of Diet, Physical Activity, BMI and Risk of Pulmonary Embolism
    Role: Co-Investigator
  4. R42HL074415 (KLINE, JEFFREY A) Mar 17, 2003 - Aug 31, 2008
    Pretest Probability Assessment for Pulmonary Embolism
    Role: Co-Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
This operation might take several minutes to complete. Please do not close your browser.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Kabrhel's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (391)
Co-Authors (96)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.